Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Major Pan-European report highlights stark inequalities in cancer treatment throughout Europe

07.10.2005


A report by the Karolinska Institutet, in conjunction with the Stockholm School of Economics, exposes stark inequalities in patient access to cancer treatment across Europe and urges action by decision makers to redress these inequalities.



The report, entitled ‘A pan-European comparison regarding patient access to cancer drugs’, found that despite the proven benefits of new innovative treatments options, patients across Europe do not have equality of access to these cancer drugs and the speed at which patients can benefit from them depends to a great extent upon the country in which they live.

Nineteen countries, representing almost 75% of Europe’s population, were included in the report. Austria, Spain, and Switzerland are shown to be the leaders in terms of early adoption and availability of new cancer drugs whereas other countries, such as the UK, Czech Republic, Hungary Norway, and Poland lag behind.


“Patients have to wait too long to obtain the benefits of newer therapies and the biggest hurdle to the uptake of new drugs is the proactive allocation of financial resources and budget in the health care systems by policy and decision makers”, says Dr. Nils Wilking of the Karolinska Institutet.

Drs Wilking and Jönsson point out that the total healthcare cost for cancer in countries included in this report is an estimated 120 euros per citizen – only 5% of total healthcare expenditure. The cost of cancer drugs per capita ranges from 7 euros to 16 euros per citizen in Europe. Costs associated with inpatient hospital care costs dominate the direct costs of cancer in Europe, accounting for 60% to 94% of all costs and less than 10% is spent on drugs. The share of health care costs for cancer is much less than the share of burden of the disease.

“A superior approach for cancer patients in Europe would be to take a broader perspective on the benefits and costs these drugs bring to patients and society, and introduce a more rational system of allocation of resources to the healthcare system,” explained Dr. Bengt Jönsson of the Stockholm School of Economics. “It is worth emphasising that new treatments are usually targeted to specifically identifiable populations” ‘he continued. Dr Jönsson also added “There are examples of best practice in some countries which try to expedite patient access to innovative therapies - these should be assessed on their applicability for more countries in Europe.”

The report also argues that while new therapies generally increase health expenditure, the value they bring to patients in terms of survival and treating their cancer must be recognized. Research undertaken in the U.S. by Dr. Frank Lichtenberg of Columbia University suggests that access to more and newer cancer drugs improves survival rates.

For further information, please contact:
Nils Wilking, mobile +46 73 625 17 19, e-mail: nils.wilking@telia.com

Bengt Jönsson, mobile +46 70 847 03 63, e-mail Bengt.Jonsson@hhs.se

Sabina Bossi | alfa
Further information:
http://info.ki.se/new_uploads/Cancer%20Report(1).pdf
http://www.ki.se

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>